Bio Blast Pharma

^{Priced, Nasdaq: ORPN}

Biotech developing treatments for rare and ultra-rare genetic diseases.

Industry: Health Care

First Day Return: -23.6%

ORPN

Biotech developing treatments for rare and ultra-rare genetic diseases.

IPO News for Bio Blast Pharma

US IPO Pricing Recap: 15 IPOs in the most active week since 2007; 66% ended at or below IPO price 08/01/14
IPO market brought down by biotech wreck and market sell off 07/31/14
Bio Blast Pharma prices IPO at $11, the low end of the range 07/31/14

IPO Data
IPO Date	07/30/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$35
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.bioblast-pharma.com
Headquarters	Tel Aviv, Israel
Founded	2012
Employees at IPO	6

IPO News for Bio Blast Pharma

Bio Blast Pharma (ORPN) Performance